Skip Navigation



Home » Drug Information » FDA Approved Drugs » 1998
Medical Areas: Cardiology/Vascular Diseases

View By:YearCompanyConditionsTherapeutic AreasDrug Names

Tricor (fenofibrate)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Abbott Laboratories
Approval Status: Approved February 1998
Treatment Area: high triglyceride levels

General Information

Tricor, a micronized form of the drug fenofibrate, has been approved for the treatment of very high triglyceride levels. Tricor is indicated as an adjunct to diet for the treatment of adults with very high serum triglyceride levels, specifically Types IV and V hyperlipidemia, who are not appropriately controlled by diet alone and are at risk of pancreatitis.